Acelyrin, Inc. (SLRN)
NASDAQ: SLRN · Real-Time Price · USD
5.68
-0.22 (-3.73%)
Oct 31, 2024, 4:00 PM EDT - Market closed
Acelyrin Market Cap
Acelyrin has a market cap or net worth of $566.91 million as of October 31, 2024. Its market cap has decreased by -42.67% in one year.
Market Cap
566.91M
Enterprise Value
-45.06M
1-Year Change
-42.67%
Ranking
Category
Stock Price
$5.68
Market Cap Chart
Since the IPO on May 5, 2023, Acelyrin's market cap has decreased from $1.67B to $566.91M, a decrease of -66.02%. That is a compound annual growth rate of -51.53%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 30, 2024 | 588.90M | -18.91% |
Dec 29, 2023 | 726.20M | -56.48% |
View and export this data all the way back to 2023.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
CureVac | 624.71M |
Revance Therapeutics | 621.08M |
Savara | 619.72M |
Tango Therapeutics | 618.76M |
CorMedix | 615.73M |
Fulgent Genetics | 609.57M |
Entrada Therapeutics | 607.68M |
Third Harmonic Bio | 599.20M |